CAR-T Cell Therapy Market Report

China CAR-T Cell Therapy Industry Market Research Report 2023-2029

  • POSTDATE：Aug 30, 2023
  • PAGES：198
  • REPORT CODE：GMM1766911
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Chimeric antigen receptors (CARs) are genetically engineered cells that are developed in the laboratory and infused into a patient to help in detecting and fighting cancer. CAR-T cell therapy is defined as a type of immunotherapy that teaches T cells to recognize and destroy cancer.

    This report elaborates on the current development of the CAR-T Cell Therapy industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Celgene Corporation

    • Pfizer, Inc

    • Kite Pharma, Inc (Gilead Sciences, Inc)

    • Novartis International AG

    • Legend Biotech (Genscript Biotech Corporation)

    • Aurora Biopharma Inc

    • Mustang Bio, Inc

    • CARsgen Therapeutics, Ltd

    By Type:

    • CD22

    • CD30

    • CD 20

    • HER1

    • CD 19

    • Meso

    • CD33

    • HER2

    • GD2

    • EGFRvlll

    By Application:

    • Leukemia

    • Non Hodgkin Leukemia

    • Hepatocellular Carcinoma

    • Multiple Myeloma

    • Acute Lymphocytic

    • Breast Cancer

    • Neuroblasta

    • Pancreatic Cancer

    • Acute Myeloid Leukemia

    • Chronic Lymphocytic Leukemia

    • Colorectal Cancer

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China CAR-T Cell Therapy Market Overview 2018-2029

    • 1.1 China CAR-T Cell Therapy Industry Development Overview

    • 1.2 China CAR-T Cell Therapy Industry Development History

    • 1.3 China CAR-T Cell Therapy Industry Market Size (2018-2029)

    • 1.4 China CAR-T Cell Therapy Market Analysis by Type from Production Side

      • 1.4.1 China CAR-T Cell Therapy Production Volume, Production Value and Growth Rate of CD22 (2018-2029)

      • 1.4.2 China CAR-T Cell Therapy Production Volume, Production Value and Growth Rate of CD30 (2018-2029)

      • 1.4.3 China CAR-T Cell Therapy Production Volume, Production Value and Growth Rate of CD 20 (2018-2029)

      • 1.4.4 China CAR-T Cell Therapy Production Volume, Production Value and Growth Rate of HER1 (2018-2029)

      • 1.4.5 China CAR-T Cell Therapy Production Volume, Production Value and Growth Rate of CD 19 (2018-2029)

      • 1.4.6 China CAR-T Cell Therapy Production Volume, Production Value and Growth Rate of Meso (2018-2029)

      • 1.4.7 China CAR-T Cell Therapy Production Volume, Production Value and Growth Rate of CD33 (2018-2029)

      • 1.4.8 China CAR-T Cell Therapy Production Volume, Production Value and Growth Rate of HER2 (2018-2029)

      • 1.4.9 China CAR-T Cell Therapy Production Volume, Production Value and Growth Rate of GD2 (2018-2029)

      • 1.4.10 China CAR-T Cell Therapy Production Volume, Production Value and Growth Rate of EGFRvlll (2018-2029)

    • 1.5 China CAR-T Cell Therapy Market Analysis by Application from Consumption End

      • 1.5.1 China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Leukemia (2018-2029)

      • 1.5.2 China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Non Hodgkin Leukemia (2018-2029)

      • 1.5.3 China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Hepatocellular Carcinoma (2018-2029)

      • 1.5.4 China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Multiple Myeloma (2018-2029)

      • 1.5.5 China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Acute Lymphocytic (2018-2029)

      • 1.5.6 China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

      • 1.5.7 China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Neuroblasta (2018-2029)

      • 1.5.8 China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Pancreatic Cancer (2018-2029)

      • 1.5.9 China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Acute Myeloid Leukemia (2018-2029)

      • 1.5.10 China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Chronic Lymphocytic Leukemia (2018-2029)

      • 1.5.11 China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Colorectal Cancer (2018-2029)

    • 1.6 China CAR-T Cell Therapy Market Analysis by Region

      • 1.6.1 North China CAR-T Cell Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China CAR-T Cell Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China CAR-T Cell Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China CAR-T Cell Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China CAR-T Cell Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China CAR-T Cell Therapy Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China CAR-T Cell Therapy Market Size and Growth Rate from 2018-2029

    Chapter 2 China CAR-T Cell Therapy Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on CAR-T Cell Therapy Market Status and Competition at home and abroad in 2023

      • 2.2.2 China CAR-T Cell Therapy Market Status and Competition Analysis in 2023

      • 2.2.3 China CAR-T Cell Therapy Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China CAR-T Cell Therapy Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on CAR-T Cell Therapy Industry Development

    Chapter 3 CAR-T Cell TherapyIndustry Chain Analysis

    • 3.1 CAR-T Cell Therapy Industry Chain

    • 3.2 CAR-T Cell Therapy Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the CAR-T Cell Therapy Market

    • 3.3 CAR-T Cell Therapy Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the CAR-T Cell Therapy Market

    Chapter 4 China CAR-T Cell Therapy Market, by Type

    • 4.1 China CAR-T Cell Therapy Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China CAR-T Cell Therapy Total Production Volume and Growth Rate from Production Side

    • 4.5 China CAR-T Cell Therapy Production Volume and Growth Rate, by Type

      • 4.5.1 China CAR-T Cell Therapy Production Volume and Growth Rate of CD22

      • 4.5.2 China CAR-T Cell Therapy Production Volume and Growth Rate of CD30

      • 4.5.3 China CAR-T Cell Therapy Production Volume and Growth Rate of CD 20

      • 4.5.4 China CAR-T Cell Therapy Production Volume and Growth Rate of HER1

      • 4.5.5 China CAR-T Cell Therapy Production Volume and Growth Rate of CD 19

      • 4.5.6 China CAR-T Cell Therapy Production Volume and Growth Rate of Meso

      • 4.5.7 China CAR-T Cell Therapy Production Volume and Growth Rate of CD33

      • 4.5.8 China CAR-T Cell Therapy Production Volume and Growth Rate of HER2

      • 4.5.9 China CAR-T Cell Therapy Production Volume and Growth Rate of GD2

      • 4.5.10 China CAR-T Cell Therapy Production Volume and Growth Rate of EGFRvlll

    Chapter 5 China CAR-T Cell Therapy Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China CAR-T Cell Therapy Total Market Size and Growth Rate from Consumption End

    • 5.5 China CAR-T Cell Therapy Market Size and Growth Rate, by Application

      • 5.5.1 China CAR-T Cell Therapy Market Size and Growth Rate of Leukemia

      • 5.5.2 China CAR-T Cell Therapy Market Size and Growth Rate of Non Hodgkin Leukemia

      • 5.5.3 China CAR-T Cell Therapy Market Size and Growth Rate of Hepatocellular Carcinoma

      • 5.5.4 China CAR-T Cell Therapy Market Size and Growth Rate of Multiple Myeloma

      • 5.5.5 China CAR-T Cell Therapy Market Size and Growth Rate of Acute Lymphocytic

      • 5.5.6 China CAR-T Cell Therapy Market Size and Growth Rate of Breast Cancer

      • 5.5.7 China CAR-T Cell Therapy Market Size and Growth Rate of Neuroblasta

      • 5.5.8 China CAR-T Cell Therapy Market Size and Growth Rate of Pancreatic Cancer

      • 5.5.9 China CAR-T Cell Therapy Market Size and Growth Rate of Acute Myeloid Leukemia

      • 5.5.10 China CAR-T Cell Therapy Market Size and Growth Rate of Chronic Lymphocytic Leukemia

      • 5.5.11 China CAR-T Cell Therapy Market Size and Growth Rate of Colorectal Cancer

    Chapter 6 China CAR-T Cell Therapy Market, by Region

    • 6.1 China CAR-T Cell Therapy Production Volume and Production Value, by Region

    • 6.2 China CAR-T Cell Therapy Sales Volume and Sales Value, by Region

    Chapter 7 North China CAR-T Cell Therapy Market Analysis

    • 7.1 North China CAR-T Cell Therapy Market, by Type

    • 7.2 North China CAR-T Cell Therapy Market, by Application

    Chapter 8 Central China CAR-T Cell Therapy Market Analysis

    • 8.1 Central China CAR-T Cell Therapy Market, by Type

    • 8.2 Central China CAR-T Cell Therapy Market, by Application

    Chapter 9 South China CAR-T Cell Therapy Market Analysis

    • 9.1 South China CAR-T Cell Therapy Market, by Type

    • 9.2 South China CAR-T Cell Therapy Market, by Application

    Chapter 10 East China CAR-T Cell Therapy Market Analysis

    • 10.1 East China CAR-T Cell Therapy Market, by Type

    • 10.2 East China CAR-T Cell Therapy Market, by Application

    Chapter 11 Northeast China CAR-T Cell Therapy Market Analysis

    • 11.1 Northeast China CAR-T Cell Therapy Market, by Type

    • 11.2 Northeast China CAR-T Cell Therapy Market, by Application

    Chapter 12 Southwest China CAR-T Cell Therapy Market Analysis

    • 12.1 Southwest China CAR-T Cell Therapy Market, by Type

    • 12.2 Southwest China CAR-T Cell Therapy Market, by Application

    Chapter 13 Northwest China CAR-T Cell Therapy Market Analysis

    • 13.1 Northwest China CAR-T Cell Therapy Market, by Type

    • 13.2 Northwest China CAR-T Cell Therapy Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Celgene Corporation

        • 14.1.1 Celgene Corporation Company Profile

        • 14.1.2 Celgene Corporation CAR-T Cell Therapy Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Pfizer, Inc

        • 14.2.1 Pfizer, Inc Company Profile

        • 14.2.2 Pfizer, Inc CAR-T Cell Therapy Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Kite Pharma, Inc (Gilead Sciences, Inc)

        • 14.3.1 Kite Pharma, Inc (Gilead Sciences, Inc) Company Profile

        • 14.3.2 Kite Pharma, Inc (Gilead Sciences, Inc) CAR-T Cell Therapy Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Novartis International AG

        • 14.4.1 Novartis International AG Company Profile

        • 14.4.2 Novartis International AG CAR-T Cell Therapy Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Legend Biotech (Genscript Biotech Corporation)

        • 14.5.1 Legend Biotech (Genscript Biotech Corporation) Company Profile

        • 14.5.2 Legend Biotech (Genscript Biotech Corporation) CAR-T Cell Therapy Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Aurora Biopharma Inc

        • 14.6.1 Aurora Biopharma Inc Company Profile

        • 14.6.2 Aurora Biopharma Inc CAR-T Cell Therapy Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Mustang Bio, Inc

        • 14.7.1 Mustang Bio, Inc Company Profile

        • 14.7.2 Mustang Bio, Inc CAR-T Cell Therapy Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 CARsgen Therapeutics, Ltd

        • 14.8.1 CARsgen Therapeutics, Ltd Company Profile

        • 14.8.2 CARsgen Therapeutics, Ltd CAR-T Cell Therapy Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 CAR-T Cell Therapy Industry Research Conclusions

    • 15.2 CAR-T Cell Therapy Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China CAR-T Cell Therapy Industry Market Size (2018-2029)

    • Figure China CAR-T Cell Therapy Production Volume, Production Value and Growth Rate of CD22 (2018-2029)

    • Figure China CAR-T Cell Therapy Production Volume, Production Value and Growth Rate of CD30 (2018-2029)

    • Figure China CAR-T Cell Therapy Production Volume, Production Value and Growth Rate of CD 20 (2018-2029)

    • Figure China CAR-T Cell Therapy Production Volume, Production Value and Growth Rate of HER1 (2018-2029)

    • Figure China CAR-T Cell Therapy Production Volume, Production Value and Growth Rate of CD 19 (2018-2029)

    • Figure China CAR-T Cell Therapy Production Volume, Production Value and Growth Rate of Meso (2018-2029)

    • Figure China CAR-T Cell Therapy Production Volume, Production Value and Growth Rate of CD33 (2018-2029)

    • Figure China CAR-T Cell Therapy Production Volume, Production Value and Growth Rate of HER2 (2018-2029)

    • Figure China CAR-T Cell Therapy Production Volume, Production Value and Growth Rate of GD2 (2018-2029)

    • Figure China CAR-T Cell Therapy Production Volume, Production Value and Growth Rate of EGFRvlll (2018-2029)

    • Figure China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Leukemia (2018-2029)

    • Figure China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Non Hodgkin Leukemia (2018-2029)

    • Figure China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Hepatocellular Carcinoma (2018-2029)

    • Figure China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Multiple Myeloma (2018-2029)

    • Figure China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Acute Lymphocytic (2018-2029)

    • Figure China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

    • Figure China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Neuroblasta (2018-2029)

    • Figure China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Pancreatic Cancer (2018-2029)

    • Figure China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Acute Myeloid Leukemia (2018-2029)

    • Figure China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Chronic Lymphocytic Leukemia (2018-2029)

    • Figure China CAR-T Cell Therapy Sales Volume, Sales Value and Growth Rate of Colorectal Cancer (2018-2029)

    • Figure North China CAR-T Cell Therapy Market Size and Growth Rate from 2018-2029

    • Figure Central China CAR-T Cell Therapy Market Size and Growth Rate from 2018-2029

    • Figure South China CAR-T Cell Therapy Market Size and Growth Rate from 2018-2029

    • Figure East China CAR-T Cell Therapy Market Size and Growth Rate from 2018-2029

    • Figure Northeast China CAR-T Cell Therapy Market Size and Growth Rate from 2018-2029

    • Figure Southwest China CAR-T Cell Therapy Market Size and Growth Rate from 2018-2029

    • Figure Northwest China CAR-T Cell Therapy Market Size and Growth Rate from 2018-2029

    • Figure CAR-T Cell Therapy Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China CAR-T Cell Therapy Market Share by Type in 2018

    • Figure China CAR-T Cell Therapy Market Share by Type in 2023

    • Figure China CAR-T Cell Therapy Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China CAR-T Cell Therapy Production Volume and Growth Rate of CD22 (2018-2023)

    • Figure China CAR-T Cell Therapy Production Volume and Growth Rate of CD30 (2018-2023)

    • Figure China CAR-T Cell Therapy Production Volume and Growth Rate of CD 20 (2018-2023)

    • Figure China CAR-T Cell Therapy Production Volume and Growth Rate of HER1 (2018-2023)

    • Figure China CAR-T Cell Therapy Production Volume and Growth Rate of CD 19 (2018-2023)

    • Figure China CAR-T Cell Therapy Production Volume and Growth Rate of Meso (2018-2023)

    • Figure China CAR-T Cell Therapy Production Volume and Growth Rate of CD33 (2018-2023)

    • Figure China CAR-T Cell Therapy Production Volume and Growth Rate of HER2 (2018-2023)

    • Figure China CAR-T Cell Therapy Production Volume and Growth Rate of GD2 (2018-2023)

    • Figure China CAR-T Cell Therapy Production Volume and Growth Rate of EGFRvlll (2018-2023)

    • Figure China CAR-T Cell Therapy Market Share by Application in 2018

    • Figure China CAR-T Cell Therapy Market Share by Application in 2023

    • Figure China CAR-T Cell Therapy Total Market Size and Growth Rate from Consumption End

    • Figure China CAR-T Cell Therapy Market Size and Growth Rate of Leukemia (2018-2023)

    • Figure China CAR-T Cell Therapy Market Size and Growth Rate of Non Hodgkin Leukemia (2018-2023)

    • Figure China CAR-T Cell Therapy Market Size and Growth Rate of Hepatocellular Carcinoma (2018-2023)

    • Figure China CAR-T Cell Therapy Market Size and Growth Rate of Multiple Myeloma (2018-2023)

    • Figure China CAR-T Cell Therapy Market Size and Growth Rate of Acute Lymphocytic (2018-2023)

    • Figure China CAR-T Cell Therapy Market Size and Growth Rate of Breast Cancer (2018-2023)

    • Figure China CAR-T Cell Therapy Market Size and Growth Rate of Neuroblasta (2018-2023)

    • Figure China CAR-T Cell Therapy Market Size and Growth Rate of Pancreatic Cancer (2018-2023)

    • Figure China CAR-T Cell Therapy Market Size and Growth Rate of Acute Myeloid Leukemia (2018-2023)

    • Figure China CAR-T Cell Therapy Market Size and Growth Rate of Chronic Lymphocytic Leukemia (2018-2023)

    • Figure China CAR-T Cell Therapy Market Size and Growth Rate of Colorectal Cancer (2018-2023)

    • Table China CAR-T Cell Therapy Production Volume by Region (2018-2023)

    • Table China CAR-T Cell Therapy Production Volume Share by Region (2018-2023)

    • Figure China CAR-T Cell Therapy Production Volume Share by Region (2018-2023)

    • Table China CAR-T Cell Therapy Production Value by Region (2018-2023)

    • Table China CAR-T Cell Therapy Production Value Share by Region (2018-2023)

    • Figure China CAR-T Cell Therapy Production Value Share by Region (2018-2023)

    • Table China CAR-T Cell Therapy Sales Volume by Region (2018-2023)

    • Table China CAR-T Cell Therapy Sales Volume Share by Region (2018-2023)

    • Figure China CAR-T Cell Therapy Sales Volume Share by Region (2018-2023)

    • Table China CAR-T Cell Therapy Sales Value by Region (2018-2023)

    • Table China CAR-T Cell Therapy Sales Value Share by Region (2018-2023)

    • Figure China CAR-T Cell Therapy Sales Value Share by Region (2018-2023)

    • Table North China CAR-T Cell Therapy Production Volume by Type (2018-2023)

    • Table North China CAR-T Cell Therapy Production Volume Share by Type (2018-2023)

    • Figure North China CAR-T Cell Therapy Production Volume Share by Type (2018-2023)

    • Table North China CAR-T Cell Therapy Sales Volume by Application (2018-2023)

    • Table North China CAR-T Cell Therapy Sales Volume Share by Application (2018-2023)

    • Figure North China CAR-T Cell Therapy Sales Volume Share by Application (2018-2023)

    • Table Central China CAR-T Cell Therapy Production Volume by Type (2018-2023)

    • Table Central China CAR-T Cell Therapy Production Volume Share by Type (2018-2023)

    • Figure Central China CAR-T Cell Therapy Production Volume Share by Type (2018-2023)

    • Table Central China CAR-T Cell Therapy Sales Volume by Application (2018-2023)

    • Table Central China CAR-T Cell Therapy Sales Volume Share by Application (2018-2023)

    • Figure Central China CAR-T Cell Therapy Sales Volume Share by Application (2018-2023)

    • Table South China CAR-T Cell Therapy Production Volume by Type (2018-2023)

    • Table South China CAR-T Cell Therapy Production Volume Share by Type (2018-2023)

    • Figure South China CAR-T Cell Therapy Production Volume Share by Type (2018-2023)

    • Table South China CAR-T Cell Therapy Sales Volume by Application (2018-2023)

    • Table South China CAR-T Cell Therapy Sales Volume Share by Application (2018-2023)

    • Figure South China CAR-T Cell Therapy Sales Volume Share by Application (2018-2023)

    • Table East China CAR-T Cell Therapy Production Volume by Type (2018-2023)

    • Table East China CAR-T Cell Therapy Production Volume Share by Type (2018-2023)

    • Figure East China CAR-T Cell Therapy Production Volume Share by Type (2018-2023)

    • Table East China CAR-T Cell Therapy Sales Volume by Application (2018-2023)

    • Table East China CAR-T Cell Therapy Sales Volume Share by Application (2018-2023)

    • Figure East China CAR-T Cell Therapy Sales Volume Share by Application (2018-2023)

    • Table Northeast China CAR-T Cell Therapy Production Volume by Type (2018-2023)

    • Table Northeast China CAR-T Cell Therapy Production Volume Share by Type (2018-2023)

    • Figure Northeast China CAR-T Cell Therapy Production Volume Share by Type (2018-2023)

    • Table Northeast China CAR-T Cell Therapy Sales Volume by Application (2018-2023)

    • Table Northeast China CAR-T Cell Therapy Sales Volume Share by Application (2018-2023)

    • Figure Northeast China CAR-T Cell Therapy Sales Volume Share by Application (2018-2023)

    • Table Southwest China CAR-T Cell Therapy Production Volume by Type (2018-2023)

    • Table Southwest China CAR-T Cell Therapy Production Volume Share by Type (2018-2023)

    • Figure Southwest China CAR-T Cell Therapy Production Volume Share by Type (2018-2023)

    • Table Southwest China CAR-T Cell Therapy Sales Volume by Application (2018-2023)

    • Table Southwest China CAR-T Cell Therapy Sales Volume Share by Application (2018-2023)

    • Figure Southwest China CAR-T Cell Therapy Sales Volume Share by Application (2018-2023)

    • Table Northwest China CAR-T Cell Therapy Production Volume by Type (2018-2023)

    • Table Northwest China CAR-T Cell Therapy Production Volume Share by Type (2018-2023)

    • Figure Northwest China CAR-T Cell Therapy Production Volume Share by Type (2018-2023)

    • Table Northwest China CAR-T Cell Therapy Sales Volume by Application (2018-2023)

    • Table Northwest China CAR-T Cell Therapy Sales Volume Share by Application (2018-2023)

    • Figure Northwest China CAR-T Cell Therapy Sales Volume Share by Application (2018-2023)

    • Table Celgene Corporation Company Profile

    • Table Celgene Corporation CAR-T Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Pfizer, Inc Company Profile

    • Table Pfizer, Inc CAR-T Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Kite Pharma, Inc (Gilead Sciences, Inc) Company Profile

    • Table Kite Pharma, Inc (Gilead Sciences, Inc) CAR-T Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Novartis International AG Company Profile

    • Table Novartis International AG CAR-T Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Legend Biotech (Genscript Biotech Corporation) Company Profile

    • Table Legend Biotech (Genscript Biotech Corporation) CAR-T Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Aurora Biopharma Inc Company Profile

    • Table Aurora Biopharma Inc CAR-T Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table Mustang Bio, Inc Company Profile

    • Table Mustang Bio, Inc CAR-T Cell Therapy Revenue, Price and Gross (2018-2023)

    • Table CARsgen Therapeutics, Ltd Company Profile

    • Table CARsgen Therapeutics, Ltd CAR-T Cell Therapy Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US